Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Vilon

KE, L-Lys-L-Glu, lysylglutamic acid

Quick Stats
Studies 40
Trials 100
Score 1
2004 pubmed

Bioregulator Vilon-induced reactivation of chromatin in cultured lymphocytes from old people.

Lezhava. Teimuraz T; Khavison. Vladimir V; Monaselidze. Jamlet J; Jokhadze. Tinatin T; Dvalishvili. Nana N; Bablishvili. Nino N; Barbakadze. Shota S

Key Findings

  • s lymphocytes",
  • ,

Practical Outcomes

  • At this stage Vilon is not ready for any DIY or supplement use. The findings are purely mechanistic and need animal or human trials to determine safety, effective dosing, and real health benefits.

Summary

A lab study found that the synthetic peptide Vilon can loosen certain tightly packed DNA structures in immune cells taken from older people, which may turn on some genes that are usually silent. However, this effect was seen only in cell cultures, not in real humans, and the study didn’t test any doses or health outcomes.

Abstract

The effect of the synthetic peptide bioregulator Vilon on structural and facultative heterochromatin of cultured lymphocytes from old people has been studied. The data obtained indicate that Vilon (a) induces unrolling (deheterochromatinization) of total heterochromatin; (b) activates synthetic processes caused by the reactivation of ribosomal genes as a result of deheterochromatinization of nucleolus organizer regions; (c) releases the genes repressed due to the condensation of euchromatic regions forming facultative heterochromatin; (d) does not induce decondensation of pericentromeric structural heterochromatin. Our results indicate that Vilon causes progressive activation (deheterochromatinization) of the facultative heterochromatin with increased aging.

Study Information

Provider

pubmed

Year

2004

DOI

10.1023/b:bgen.0000025070.90330.7f